Brief: Eckert & Ziegler Establishes Joint Venture With Dc Pharma

Eckert & Ziegler SE

14/11/2023 11:09

Nov 14 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG  EUZG.DE :
    * ESTABLISHES GERMAN-CHINESE JOINT VENTURE WITH DC PHARMA
FOR
PRODUCTION OF RADIOISOTOPES
    * TODAY SIGNED A 50:50 JOINT VENTURE AGREEMENT WITH CHINESE
PHARMACEUTICAL COMPANY DONGCHENG PHARMA (DC PHARMA).
    * JOINT VENTURE WILL COMPLETE PRODUCTION FACILITY CURRENTLY
UNDER
CONSTRUCTION IN JINTAN AND START PRODUCTION OF CYCLOTRON-BASED
ISOTOPES IN A FIRST PHASE
    * DC PHARMA INVESTS EUR 20 MILLION IN EZAG SUBSIDIARY QI
KANG
MEDICAL TECHNOLOGY (CHANGZHOU) CO., LTD. BY WAY OF A CAPITAL
INCREASE AND WILL SUBSEQUENTLY HOLD 50% OF SHARES.

Source text for Eikon:  ID:nEQ8y33fva 
Further company coverage:  EUZG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))